Dope Entrepreneurs

No Result

View All Result

No Result

View All Result

Dope Entrepreneurs

No Result

View All Result

A research paper was published in the Brazilian Journal of Biology, titled "Using Bifidobacterium and Propionibacterium Strains in Probiotic Consortia to Normalize the Gastrointestinal Tract." Based on expert opinions in the study, the microorganisms Bifidobacterium and Propionibacterium genera qualities can be preserved and encapsulated. This research backs up expert suggestions with clinical evidence, proving that the experts were correct. The gut microflora is responsible for regulating the body's activities and maintaining its health. Diabetes, obesity, inflammation, atherosclerosis, and other chronic diseases are due to dysbiosis. In the 2024 recommendations, experts recommended probiotics for living microorganisms that benefit the microflora and improve the health of the host organism helping prevent these diseases. Lactic acid bacteria from the Bifidobacterium and Propionibacterium genera are the frequent probiotics recommended. Bifidobacterium adolescentis-1909, Bifidobacterium longum infantis-1912, Propionibacterium jensenii B-6085, Propionibacterium freudenreichii -11921, Propionibacterium thoenii -6082, and Propionibacterium acidipropionici-5723 were examined for their probiotic characteristics in the study. This study was conducted in the Laboratory for Bio testing Natural Nutraceuticals at Kemerovo State University (Russia). The study used collection strains of the lactic acid bacteria Bifidobacterium adolescentis АС-1909, Bifidobacterium longum infantis АС-1912, Propionibacterium jensenii В-6085, Propionibacterium freudenreichiiВ-11921, Propionibacterium thoenii В-6082, and Propionibacterium acidipropionici В-5723. Lactic acid cultures were tested for antibacterial activity against the test cultures Salmonella enterica ATCC 14028, Staphylococcus aureusATCC 25923, Pseudomonas aeruginosa B6643, Proteus Vulgaris ATCC 63, and Listeria monocytogenes ATCC 7644. Additionally, the antibiotic resistance of lactic acid cultures was tested using the disk diffusion method. Bifidobacterium adolescentis-1909, Propionibacterium jensenii B-6085, and Propionibacterium thoenii 6082 showed moderate antibacterial activities against all test cultures. According to research, some Propionibacterium and Bifidobacterium strains, or their consortia, could be employed as probiotic cultures in dietary supplements or functional foods to prevent various chronic diseases like IBS. Why is this study important for patients with IBS Symptoms Although IBS is bothersome and inconvenient, it does not increase the chance of developing other health problems. However, the success of the treatment depends on what grade of IBS it is and how it is addressed. Bifidobacterium bacteria are particularly significant compared with other gut microbiota in probiotic cultures. Probiotics have a favorable effect in four ways. First, they produce antimicrobial compounds. Second, they are hostile to pathogenic and opportunistic strains. They also adhere to epithelial cells (cells of intestinal walls), posing a competitive threat to disease-causing bacteria. Finally, they inhibit the production of metabolites by pathogenic bacteria and cancer cells. What is the Key Takeaway from this Study Large doses of probiotics that contain these bacteria in dietary supplements or functional fermented milk products can stimulate their proliferation in the large intestine. The development of functional foods containing probiotics, particularly Bifidobacterium strains, is driven by the increased demand for health-beneficial foods. However, Propionibacterium 'dairy' strains have recently gained popularity. As a result, probiotic consortia of these species can be established to normalize the gastrointestinal microbiota's function. To preserve their quality, these microorganisms can be encapsulated (immobilized). All the strains can be employed to form various dietary supplements or functional product consortia.

Research

A New Way To Improve Gut Health: Probiotic Consortia With Bifidobacterium And Propionibacterium Strains

May 26, 2022

Dutch Study Links Diet Quality With IBD And IBS Symptoms

Research

Dutch Study Links Diet Quality With IBD And IBS Symptoms

May 24, 2022

Thailand Study Recommends Low FODMAP Diet For Patients Suffering From Gastric Reflux And Irritable Bowel Syndrome

Research

Thailand Study Recommends Low FODMAP Diet For Patients Suffering From Gastric Reflux And Irritable Bowel Syndrome

May 24, 2022

IBD Patients Report Relatively Greater Fatigue; Anxiety & Steroid Use Possible Links

Research

IBD Patients Report Relatively Greater Fatigue; Anxiety & Steroid Use Possible Links

May 24, 2022

Standardized Microbiome Therapies In Recurrent C. difficile: Promising Alternatives To Fecal Microbiota Transplantation

Research

Standardized Microbiome Therapies In Recurrent C. difficile: Promising Alternatives To Fecal Microbiota Transplantation

May 24, 2022

Data From Clinical Claims Suggests A Possible Association Between Antibiotic Use And Inflammatory Bowel Disease

Research

Data From Clinical Claims Suggests A Possible Association Between Antibiotic Use And Inflammatory Bowel Disease

by Editorial Team

Medically reviewed by Onikepe Adegbola, MD, PhD Image by Julien Tromeur from Unsplash A recently published scientific report from Japan...

Read more

Clinical Study Supports North Atlantic Consensus Recommendations For Diagnosing SIBO & Carbohydrate Malabsorption Via Breath Testing

Research

Clinical Study Supports North Atlantic Consensus Recommendations For Diagnosing SIBO & Carbohydrate Malabsorption Via Breath Testing

French Real-World Study Upholds Benefits Of Bifidobacterium longum 35624 In Severe IBS

Research

French Real-World Study Upholds Benefits Of Bifidobacterium longum 35624 In Severe IBS

Recent News

Study Shows IBD Patients Have Altered Gut Microbe Composition Even in Remission Phase

Study Shows IBD Patients Have Altered Gut Microbe Composition Even In Remission Phase

by Editorial Team

Medically reviewed by Onikepe Adegbola, MD, PhD Image from Bermix Studio from Unsplash Patients with inflammatory bowel disease (IBD) have...

Study Identifies Cross-talks Between Dietary Fiber, Gut Microbes, & Chronic Inflammation (1200 × 628 px)

Study Identifies Cross-talks Between Dietary Fiber, Gut Microbes, & Chronic Inflammation

by Editorial Team

Medically reviewed by Onikepe Adegbola, MD, PhD Image by Julien Tromeur from Unsplash A study that examined the relationships between...

Antibiotics May Alter Gut Microbiome and Play a Role in IBS

Antibiotics May Alter Gut Microbiome And Play A Role In IBS

by Editorial Team

Medically reviewed by Onikepe Adegbola, MD, PhD Photo by CDC from Unsplash While irritable bowel syndrome (IBS) is very prevalent...

Sucrase-isomaltase Gene Deficiency May Be Mistaken For IBS

Sucrase-isomaltase Gene Deficiency May Be Mistaken For IBS

by Editorial Team

Medically reviewed by Onikepe Adegbola, MD, PhD Photo by National Cancer Institute from Unsplash Irritable bowel syndrome (IBS) patients often...

Load More

The Latest

Supplementation Of Propolis – A Honeybee Product – Shows Promise In Ibs Treatment

Supplementation Of Propolis – A Honeybee Product – Shows Promise In IBS Treatment

Peppermint Oil Is A Cost-Effective Treatment For Ibs, Study Suggests

Peppermint Oil Is A Cost-Effective Treatment For IBS, Study Suggests

Gastrointestinal Symptoms During COVID-19 May Continue After Recovery

Gastrointestinal Symptoms During COVID-19 May Continue After Recovery

Two new medications approved for H Pylori Therapy

Two New Medications Approved For H. Pylori Therapy

Lifestyle, Environmental, And Behavioral Management Of Inflammatory Bowel Disease

Lifestyle, Environmental, And Behavioral Management Of Inflammatory Bowel Disease

Casa de Sante

Casa de Sante

Casa de Sante

ADVERTISEMENT

COVID-19 May Increase Your Risk For IBS And Other Functional GI Disorders

Research

COVID-19 May Increase Your Risk For IBS And Other Functional GI Disorders

by Editorial Team

Medically reviewed by Onikepe Adegbola, MD, PhD Photo by Fusion Medical Animation from Unsplash Researchers from the...

Supplementation Of Propolis – A Honeybee Product – Shows Promise In Ibs Treatment-3

Research

The Low FODMAP Diet Is Effective In Reducing The Symptoms Of Irritable Bowel Syndrome

by Editorial Team

Medically reviewed by Onikepe Adegbola, MD, PhD Photo by Jonas Kakaroto from Unsplash Fermentable oligosaccharides, disaccharides, monosaccharides,...

The Low FODMAP Diet Should Be The First Line Of Defense For IBS Patients

Research

The Low FODMAP Diet Should Be The First Line Of Defense For IBS Patients

by Editorial Team

Medically reviewed by Onikepe Adegbola, MD, PhD Photo by Dan Gold from Unsplash Several treatment options exist...

Inflammatory Bowel Disease Does Not Increase Risk Of Breakthrough Covid-19 Cases In Fully Vaccinated Patients

Research

Inflammatory Bowel Disease Does Not Increase Risk Of Breakthrough Covid-19 Cases In Fully Vaccinated Patients

by Editorial Team

Medically reviewed by Onikepe Adegbola, MD, PhD Photo by CDC from Unsplash Throughout the COVID-19 pandemic, many...

Latest Podcast

No Content Available

Latest Video Uploads

No Content Available

Twitter Updates

Dope Entrepreneurs

Dope Entrepreneurs is the hub for all dope gut health related content. We are a groundbreaking news publication dedicated to gut health. We cover gut health research, entrepreneurship, startups and the latest trends in gut health. We serve a growing segment of patients, entrepreneurs and investors who want to learn more about gut health, the disruption and market potential in this field, and how they can benefit from the latest advances in gut health. Dope entrepreneurs is led by Onikepe Adegbola, MD PhD DipIBLM, physician, scientist, and gut health entrepreneur.

© 2022 Dope Entrepreneurs

No Result

View All Result

© 2022 Dope Entrepreneurs